Nitric oxide and vascular responses in Type I diabetes

Diabetologia

Volumn 43, Issue 2, 2000, Pages 137-147

  Chan, N N ^a   Vallance, P ^a   Colhoun, H M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelium; Flow mediated dilatation; Nitric oxide; Plethysmography; Type I diabetes; Vascular ultrasound; Vasodilatation

Indexed keywords

NITRIC OXIDE;

BLOOD VESSEL REACTIVITY; ECHOGRAPHY; INSULIN DEPENDENT DIABETES MELLITUS; MICROANGIOPATHY; PLETHYSMOGRAPHY; PRIORITY JOURNAL; REVIEW; ULTRASOUND THERAPY; VASCULAR DISEASE; VASODILATATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; NITRIC OXIDE;

EID: 0034003042     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050022     Document Type: Review

References (127)

1. 1. Head J, Fuller JH (1990) International variations in mortality among diabetic patients: the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 33: 477-481
2. 2. Fuller JH, Elford J, Goldblatt P, Adelstein AM (1983) Diabetes mortality: new light on an underestimated public health problem. Diabetologia 24: 336-341
3. 3. Dorman JS, Laporte RE, Kuller LH et al. (1984) The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results. Diabetes 33: 271-276
4. 4. Krolewski AS, Kosinski EJ, Warram JH et al. (1987) Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59: 750-755
5. 5. Morrish NJ, Stevens LK, Fuller JH, Jarrett RJ, Keen H (1991) Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia 34: 590-594
6. 6. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
7. 7. Garg UC, Hassid A (1989) Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83: 1774-1777
8. 8. Porta M, La Selva M, Molinatti P, Molinatti GM (1987) Endothelial cell function in diabetic microangiopathy. Diabetologia 30: 601-609
9. 9. Jensen T, Bjerre Knudsen J, Feldt Rasmussen B, Deckert T (1989) Features of endothelial dysfunction in early diabetic nephropathy. Lancet i: 461-463
10. 10. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524-526
11. 11. Kushner B, Lazar M, Furman M, Lieberman TW, Leopold IH (1969) Resistance of rabbits and guinea pigs to the diabetogenic effect of streptozotocin. Diabetes 18: 542-544
12. 12. Hadcock S, Richardson M, Winocour PD, Hatton MW (1991) Intimal alterations in rabbit aortas during the first 6 months of alloxan-induced diabetes. Arterioscler Thromb 11: 517-529
13. 13. Grunwald J, Hesz A, Robenek H, Brucker J, Buddecke E (1985) Proliferation, morphology, and low-density lipoprotein metabolism of arterial endothelial cells cultured from normal and diabetic minipigs. Exp Mol Pathol 42: 60-70
14. 14. Lin SJ, Hong CY, Chang MS, Chiang BN, Chien S (1993) Increased aortic endothelial death and enhanced transendothelial macromolecular transport in streptozotocin-diabetic rats. Diabetologia 36: 926-930
15. 15. Aageneas O, Moe H (1961) Light and electron microscopy study of skin capillaries of diabetics. Diabetes 10: 253-259
16. 16. Rosenstock J, Challis P, Strowig S, Raskin P (1988) Improved diabetes control reduces skeletal muscle capillary basement membrane width in insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 4: 167-175
17. 17. Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJ, Ward JD (1993) Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36: 454-459
18. 18. Matikainen E, Leinonen H, Juntunen J (1982) Capillary morphology and muscle blood flow in diabetic neuropathy. Eur Neurol 21: 22-28
19. 19. Yasuda H, Dyck PJ (1987) Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology 37: 20-28
20. 20. Malik RA, Newrick PG, Sharma AK et al. (1989) Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32: 92-102
21. 21. Leinonen H, Matikainen E, Juntunen J (1982) Permeability and morphology of skeletal muscle capillaries in Type I (insulin-dependent) diabetes mellitus. Diabetologia 22: 158-162
22. 22. Cester N, Rabini RA, Salvolini E et al. (1996) Activation of endothelial cells during insulin-dependent diabetes mellitus: a biochemical and morphological study. Eur J Clin Invest 26: 569-573
23. 23. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288: 373-376
24. 24. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84: 9265-9269
25. 25. Schmidt HH, Nau H, Wittfoht W et al. (1988) Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol 154: 213-216
26. 26. Palmer RM, Ashton DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666
27. 27. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012
28. 28. Wennmalm A, Benthin G, Edlund A et al. (1993) Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73: 1121-1127
29. 29. Furchgott RF (1984) The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 24: 175-197
30. 30. Griffith TM, Edwards DH, Lewis MJ, Newby AC, Henderson AH (1984) The nature of endothelium-derived vascular relaxant factor. Nature 308: 645-647
31. 31. Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65: 1-21
32. 32. Vallance P, Collier J, Moncada S (1989) Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet ii: 997-1000
33. 33. Pohl U, Holtz J, Busse R, Bassenge E (1986) Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 8: 37-44
34. 34. Tada M, Kirchberger MA, Katz AM (1975) Phosphorylation of a 22,000-dalton component of the cardiac sarcoplasmic reticulum by adenosine 3′:5′-monophosphate-dependent protein kinase. J Biol Chem 250: 2640-2647
35. 35. Hutcheson IR, Griffith TM (1991) Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow. Am J Physiol 261: H257-H262
36. 36. Lamontagne D, Pohl U, Busse R (1992) Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res 70: 123-130
37. 37. Pohl U, Busse R (1989) Hypoxia stimulates release of endothelium-derived relaxant factor. Am J Physiol 256: H1595-H1600
38. 38. Newby AC, Henderson AH (1990) Stimulus-secretion coupling in vascular endothelial cells. Annu Rev Physiol 52: 661-674
39. 39. Hecker M, Siegle I, Macarthur H, Sessa WC, Vane JR (1992) Role of intracellular thiols in release of EDRF from cultured endothelial cells. Am J Physiol 262: H888-H896
40. 40. Busse R, Mulsch A, Fleming I, Hecker M (1993) Mechanism of nitric oxide release from the vascular endothelium. Circulation 87:V18-V25
41. 41. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179
42. 42. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87: 432-438
43. 43. Weisbrod RM, Brown ML, Cohen RA (1993) Effect of elevated glucose on cyclic GMP and eicosanoids produced by porcine aortic endothelium. Arterioscler Thromb 13: 915-923
44. 44. Poston L, Taylor PD (1995) Glaxo/MRS Young Investigator Prize. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci (Colch) 88: 245-255
45. 45. Pieper GM (1998) Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060
46. 46. Schaffler A, Arndt H, Scholmerich J, Palitzsch K (1998) Acute hyperglycaemia causes severe disturbances of mesenteric microcirculation in an in vivo rat model. Eur J Clin Invest 28: 886-893
47. 47. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A (1998) Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg 28: 687-694
48. 48. Williams SB, Goldfine AB, Timimi FK et al. (1998) Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97: 1695-1701
49. 49. Kawano H, Motoyama T, Hirashima O et al. (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34: 146-154
50. 50. Hogan M, Cerami A, Bucala R (1992) Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 90: 1110-1115
51. 51. Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P (1994) Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94: 2511-2515
52. 52. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AD (1994) Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179
53. 53. Makimattila S, Mantysaari M, Groop PH et al. (1997) Hyperreactivity to nitrovasodilators in forearm vasculature is related to autonomic dysfunction in insulin-dependent diabetes mellitus. Circulation 95: 618-625
54. 54. Elliott TG, Cockcroft JR, Groop PH, Viberti GC, Ritter JM (1993) Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin Sci Colch 85: 687-693
55. 55. Oyama Y, Kawasaki H, Hattori Y, Kanno M (1986) Attenuation of endothelium-dependent relaxation in aorta from diabetic rats. Eur J Pharmacol 132: 75-78
56. 56. Miyata N, Tsuchida K, Okuyama S, Otomo S, Kamata K, Kasuya Y (1992) Age-related changes in endothelium-dependent relaxation in aorta from genetically diabetic WBN/Kob rats. Am J Physiol 262: H1104-H1109
57. 57. Head RJ, Longhurst PA, Panek RL, Stitzel RE (1987) A contrasting effect of the diabetic state upon the contractile responses of aortic preparations from the rat and rabbit. Br J Pharmacol 91: 275-286
58. 58. Harris KH, MacLeod KM (1988) Influence of the endothelium on contractile responses of arteries from diabetic rats. Eur J Pharmacol 153: 55-64
59. 59. Mulhern M, Docherty JR (1989) Effects of experimental diabetes on the responsiveness of rat aorta. Br J Pharmacol 97: 1007-1012
60. 60. Brands MW, Fitzgerald SM (1998) Acute endothelium-mediated vasodilation is not impaired at the onset of diabetes. Hypertension 32: 541-547
61. 61. Taylor PD, Wickenden AD, Mirrlees DJ, Poston L (1994) Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat. Br J Pharmacol 111: 42-48
62. 62. Alsip NL, Schuschke DA, Miller FN (1996) Microvascular responses in the skeletal muscle of the diabetic rat. J Lab Clin Med 128: 429-437
63. 63. Keegan A, Cotter MA, Cameron NE (1999) Effects of diabetes and treatment with the antioxidant alpha-lipoic acid on endothelial and neurogenic responses of corpus cavernosum in rats. Diabetologia 42: 343-350
64. 64. Kihara M, Low PA (1995) Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp Neurol 132: 180-185
65. 65. Gebremedhin D, Koltai MZ, Pogatsa G, Magyar K, Hadhazy P (1999) Influence of experimental diabetes on the mechanical responses of canine coronary arteries: role of endothelium. Cardiovasc Res 22: 537-544
66. 66. Heygate KM, Lawrence IG, Bennett MA, Thurston H (1995) Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br J Pharmacol 116: 3251-3259
67. 67. Altan VM, Karasu C, Ozuari A (1989) The effects of type-1 and type-2 diabetes on endothelium-dependent relaxation in rat aorta. Pharmacol Biochem Behav 33: 519-522
68. 68. Wakabayashi I, Hatake K, Kimura N, Kakishita E, Nagai K (1999) Modulation of vascular tone by the endothelium in experimental diabetes. Life Sci 40: 643-648
69. 69. Lash JM, Bohlen HG (1991) Structural and functional origins of supressed acetylcholine vasodilation in diabetic rat intestinal arterioles. Circ Res 69: 1259-1268
70. 70. Diederich D, Skopec J, Diederich A, Dai FX (1994) Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266: H1153-H1161
71. 71. Kiff RJ, Gardiner SM, Compton AM, Bennett T (1991) Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus. Br J Pharmacol 103: 1357-1362
72. 72. Pieper GM (1999) Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration. Diabetologia 42: 204-213
73. 73. McNally PG, Watt PA, Rimmer T, Burden AC, Hearnshaw JR, Thurston H (1994) Impaired contraction and endothelium-dependent relaxation in isolated resistance vessels from patients with insulin-dependent diabetes mellitus. Clin Sci (Colch) 87: 31-36
74. 74. Malik RA, Paniagua O, Shaw L, Austin C, Heagerty AM (1999) Resistance vessel function and structure in normotensive patients with Type I diabetes. Diabetologia 42[Suppl 1]:A75 (Abstract)
75. 75. Benjamin N, Calver A, Collier J, Robinson B, Vallance P, Webb D (1995) Measuring forearm blood flow and interpreting the responses to drugs and mediators. Hypertension 25: 918-923
76. 76. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516
77. 77. Makimattila S, Virkamaki A, Groop PH et al. (1996) Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation 94: 1276-1282
78. 78. O'Driscoll G, Green D, Rankin J, Stanton K, Taylor R (1997) Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. J Clin Invest 100: 678-684
79. 79. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T (1993) Endothelium-dependent vascular relaxation in patients with type I diabetes. Diabetes 42: 148-153
80. 80. Huvers FC, De Leeuw PW, Houben AJ et al. (1999) Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes 48: 1300-1307
81. 81. Halkin A, Benjamin N, Doktor HS, Todd SD, Viberti G, Ritter JM (1991) Vascular responsiveness and cation exchange in insulin-dependent diabetes. Clin Sci (Colch) 81: 223-232
82. 82. Calver A, Collier J, Vallance P (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90: 2548-2554
83. 83. Celermajer DS (1998) Testing endothelial function using ultrasound. J Cardiovasc Pharmacol 32[Suppl 3]: S29-S32
84. 84. Lambert J, Aarsen M, Donker AJ, Stehouwer CD (1996) Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 16: 705-711
85. 85. Zenere BM, Arcaro G, Saggiani F, Rossi L, Muggeo M, Lechi A (1995) Noninvasive detection of functional alterations of the arterial wall in IDDM patients with and without microalbuminuria. Diabetes Care 18: 975-982
86. 86. Enderle MD, Benda N, Schmuelling RM, Haering HU, Pfohl M (1998) Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care 21: 271-277
87. 87. Lekakis J, Papamichael C, Anastasiou H et al. (1997) Endothelial dysfunction of conduit arteries in insulin-dependent diabetes mellitus without microalbuminuria. Cardiovasc Res 34: 164-168
88. 88. Anderson TJ, Uehata A, Gerhard MD et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26: 1235-1241
89. 89. Hardie KL, Kinlay S, Hardy DB, Wlodarczyk J, Silberberg JS, Fletcher PJ (1997) Reproducibility of brachial ultrasonography and flow-mediated dilatation (FMD) for assessing endothelial function. Aust N Z J Med 27: 649-652
90. 90. Celermajer DS, Sorensen KE, Gooch VM et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340: 1111-1115
91. 91. Clarkson P, Celermajer DS, Donald AE et al. (1996) Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels. J Am Coll Cardiol 28: 573-579
92. 92. Meeking DR, Cummings MH, Thorne S et al. (1999) Endothelial dsyfunction in type 1 diabetic subjects with and without microalbuminuria. Diabet Med 16: 841-847
93. 93. Chowienczyk PJ, Cockcroft JR, Ritter JM (1994) Blood flow responses to intra-arterial acetylcholine in man: effects of basal flow and conduit vessel length. Clin Sci (Colch) 87: 45-51
94. 94. Duff F, Greenfield ADM, Shepherd JT, Thompson ID (1953) A quantitative study of the response to acetylcholine and histamine of the blood vessels of the human hand and forearm. J Physiol (Lond) 120: 160-170
95. 95. Chowienczyk PJ, Cockcroft JR, Ritter JM (1993) Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br J Pharmacol 110: 736-738
96. 96. Steinberg HO, Baron AD (1997) Insulin-dependent diabetes mellitus and nitrovasodilation. Important and complex interactions. Circulation 95: 560-561
97. 97. Colhoun HM, Chaturvedi N, Fuller JH (1999) Increased coronary artery calcification in young women with type 1 diabetes compared with the general population. Diabet Med 16: A66 (Abstract)
98. 98. Tesfamariam B, Cohen RA (1992) Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263: H321-H326
99. 99. Tesfamariam B (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med 16: 383-391
100. 100. Giugliano D, Ceriello A, Paolisso G (1996) Oxidative stress and diabetic vascular complications. Diabetes Care 19: 257-267
101. 101. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF (1997) High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 96: 25-28
102. 102. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87: 1620-1624
103. 103. Squadrito GL, Pryor WA (1995) The formation of peroxynitrite in vivo from nitric oxide and superoxide. Chem Biol Interact 96: 203-206
104. 104. Tate RM, Morris HG, Schroeder WR, Repine JE (1984) Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J Clin Invest 74: 608-613
105. 105. Jackson RM, Chandler DB, Fulmer JD (1986) Production of arachidonic acid metabolites by endothelial cells in hyperoxia. J Appl Physiol 61: 584-591
106. 106. Hattori Y, Kawasaki H, Abe K, Kanno M (1991) Superoxide dismutase recovers altered endothelium-dependent relaxation in diabetic rat aorta. Am J Physiol 261: H1086-H1094
107. 107. Diederich D, Skopec J, Diederich A, Dai FX (1994) Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 266: H1153-H1161
108. 108. O'Byrne S, Forte P, Johnston A et. al. (1999) Basal nitric oxide turnover and oxidative stress levels in insulin-dependent diabetes mellitus. Diabet Med 16: A18 (Abstract)
109. 109. Hawthorne GC, Bartlett K, Hetherington CS, Alberti KG (1989) The effect of high glucose on polyol pathway activity and myoinositol metabolism in cultured human endothelial cells. Diabetologia 32: 163-166
110. 110. Gonzalez RG, Barnett P, Aguayo J, Cheng HM, Chylack LT Jr (1984) Direct measurement of polyol pathway activity in the ocular lens. Diabetes 33: 196-199
111. 111. Kern TS, Engerman RL (1982) Immunohistochemical distribution of aldose reductase. Histochem J 14: 507-515
112. 112. Asahina T, Kashiwagi A, Nishio Y et al. (1995) Impaired activation of glucose oxidation and NADPH supply in human endothelial cells exposed to H2O2 in high-glucose medium. Diabetes 44: 520-526
113. 113. Cameron NE, Cotter MA (1992) Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of polyol pathway. Diabetologia 35: 1011-1019
114. 114. Tesfamariam B, Palacino JJ, Weisbrod RM, Cohen RA (1993) Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J Cardiovasc Pharmacol 21: 205-211
115. 115. Sakakibara F, Hotta N, Koh N, Sakamoto N (1993) Effects of high glucose concentrations and epalrestat on sorbitol and myo-inositol metabolism in cultured rabbit aortic smooth muscle cells. Diabetes 42: 1594-1600
116. 116. Park JY, Ha SW, King GL (1999) The role of protein kinase C activation in the pathogenesis of diabetic vascular complications. Perit Dial Int 19[Suppl 2]: S222-227
117. 117. Wolf BA, Williamson JR, Easom RA, Chang K, Sherman WR, Turk J (1991) Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 87: 31-38
118. 118. Tesfamariam B, Brown ML, Cohen RA (1991) Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 87: 1643-1648
119. 119. Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315-1321
120. 120. Brownlee M, Vlassara H, Cerami A (1984) Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med 101: 527-537
121. 121. Vlassara H, Brownlee M, Cerami A (1985) High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules. Proc Natl Acad Sci USA 82: 5588-5592
122. 122. Radoff S, Vlassara H, Cerami A (1988) Characterization of a solubilized cell surface binding protein on macrophages specific for proteins modified nonenzymatically by advanced glycosylated end products. Arch Biochem Biophys 263: 418-423
123. 123. Makita Z, Radoff S, Rayfield EJ et al. (1991) Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 325: 836-842
124. 124. Bucala R, Tracey KJ, Cerami A (1991) Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87: 432-438
125. 125. Hogan M, Cerami A, Bucala R (1992) Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J Clin Invest 90: 1110-1115
126. 126. Edelstein D, Brownlee M (1992) Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats. Diabetologia 35: 96-97
127. 127. Soulis T, Cooper ME, Vranes D, Bucala R, Jerums G (1996) Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment. Kidney Int 50: 627-634